AJP - Renal Physiology, Vol 266, Issue 1 135-F138, Copyright © 1994 by American Physiological Society

ARTICLES

Effect of an endothelin-receptor antagonist on ischemic acute renal failure

L. Chan, A. Chittinandana, J. I. Shapiro, P. F. Shanley and R. W. Schrier
Department of Medicine, University of Colorado School of Medicine, Denver 80262.

In the isolated perfused rat kidney, endothelin (ET) added to the perfusate at concentrations ranging from 50 to 500 pmol/l resulted in a dose-dependent reduction in renal perfusate flow (RPF) and inulin clearance (CIn). The decrease in RPF (17 +/- 3 vs. 34 +/- 3 ml.min-1 x g-1; P < 0.01 compared with control) and CIn (89 +/- 13 vs. 317 +/- 19 microliters.min-1 x g-1; P < 0.01 compared with control) by ET (500 pmol/l) was prevented by the ET antagonist BQ-123 (10 microM), with full recovery of RPF [36 +/- 2 vs. 34 +/- 3 ml.min-1 x g-1; not significant (NS) compared with control] and CIn (299 +/- 51 vs. 317 +/- 19 microliters.min-1 x g-1; NS compared with control). In the absence of ET, perfusion of the kidney with a similar concentration of BQ-123 (10 microM) did not induce any changes in RPF (36 +/- 5 vs. 34 +/- 3 ml.min-1 x g-1; NS compared with control) or CIn (320 +/- 14 vs. 317 +/- 19 microliters.min-1 x g-1; NS compared with control). After 60 min of arterial clamping, BQ-123 (10 microM) given before the onset of ischemia and during reflow improved CIn (88 +/- 4 vs. 19 +/- 3 microliters.min-1 x g-1; n = 6, P < 0.01) and net tubular sodium reabsorption (TNa) compared with no treatment. On the other hand, the same dose (10 microM) of BQ-123 given only during the reperfusion period was not effective in preventing the decreases in either CIn or TNa.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				E. H. Bae, K. S. Lee, J. Lee, S. K. Ma, N. H. Kim, K. C. Choi, J. Frokiaer, S. Nielsen, S. Y. Kim, S. Z. Kim, et al. Effects of {alpha}-lipoic acid on ischemia-reperfusion-induced renal dysfunction in rats Am J Physiol Renal Physiol, January 1, 2008; 294(1): F272 - F280. [Abstract] [Full Text] [PDF]

				C. Haug, A. Schmid-Kotsas, T. Linder, M. G. Bachem, A. Gruenert, and E. Rozdzinski Influence of hepatocyte growth factor, epidermal growth factor, and mycophenolic acid on endothelin-1 synthesis in human endothelial cells Nephrol. Dial. Transplant., December 1, 2001; 16(12): 2310 - 2316. [Abstract] [Full Text] [PDF]

				A. Kato and A. Hishida Amelioration of post-ischaemic renal injury by contralateral uninephrectomy: a role of endothelin-1 Nephrol. Dial. Transplant., August 1, 2001; 16(8): 1570 - 1576. [Abstract] [Full Text] [PDF]

				M. FOSCHI, A. SOROKIN, P. PRATT, A. MCGINTY, G. L. VILLA, F. FRANCHI, and M. J. DUNN PreproEndothelin-1 Expression in Human Mesangial Cells: Evidence for a p38 Mitogen-Activated Protein Kinase/Protein Kinases-C--Dependent Mechanism J. Am. Soc. Nephrol., June 1, 2001; 12(6): 1137 - 1150. [Abstract] [Full Text]

				N. LAMEIRE and R. VANHOLDER Pathophysiologic Features and Prevention of Human and Experimental Acute Tubular Necrosis J. Am. Soc. Nephrol., February 1, 2001; 12(90001): 20S - 32. [Abstract] [Full Text]

				S. Akhteruzzaman, Y. Kato, A. Hisaka, and Y. Sugiyama Primary Active Transport of Peptidic Endothelin Antagonists by Rat Hepatic Canalicular Membrane J. Pharmacol. Exp. Ther., February 1, 1999; 288(2): 575 - 581. [Abstract] [Full Text]

				E. Petrossian, A. J. Parry, V. M. Reddy, G. P. Akkersdijk, D. M. McMullan, L. Thompson, K. D. Hendricks-Munoz, H. Hallak, F. L. Hanley, and J. R. Fineman ENDOTHELIN RECEPTOR BLOCKADE PREVENTS THE RISE IN PULMONARY VASCULAR RESISTANCE AFTER CARDIOPULMONARY BYPASS IN LAMBS WITH INCREASED PULMONARY BLOOD FLOW J. Thorac. Cardiovasc. Surg., February 1, 1999; 117(2): 314 - 323. [Abstract] [Full Text] [PDF]

				Y. Matsumura, N. Hashimoto, S. Taira, T. Kuro, R. Kitano, M. Ohkita, T. J. Opgenorth, and M. Takaoka Different Contributions of Endothelin-A and Endothelin-B Receptors in the Pathogenesis of Deoxycorticosterone Acetate–Salt–Induced Hypertension in Rats Hypertension, February 1, 1999; 33(2): 759 - 765. [Abstract] [Full Text] [PDF]

				Y. Matsumura, M. Nishiura, S. Deguchi, N. Hashimoto, T. Ogawa, and R. Seo Protective Effect of FK409, a Spontaneous Nitric Oxide Releaser, on Ischemic Acute Renal Failure in Rats J. Pharmacol. Exp. Ther., December 1, 1998; 287(3): 1084 - 1091. [Abstract] [Full Text]

				V. M. Reddy, K. D. Hendricks-Munoz, H. A. Rajasinghe, E. Petrossian, F. L. Hanley, and J. R. Fineman Post–Cardiopulmonary Bypass Pulmonary Hypertension in Lambs With Increased Pulmonary Blood Flow: A Role for Endothelin 1 Circulation, February 18, 1997; 95(4): 1054 - 1061. [Abstract] [Full Text]

				R. Thadhani, M. Pascual, and J. V. Bonventre Acute Renal Failure N. Engl. J. Med., May 30, 1996; 334(22): 1448 - 1460. [Full Text] [PDF]

				E. R. Levin Endothelins N. Engl. J. Med., August 10, 1995; 333(6): 356 - 363. [Full Text] [PDF]

				P. Wiesel, A. P. Patel, I. M. Carvajal, Z. Y. Wang, A. Pellacani, K. Maemura, N. DiFonzo, H. G. Rennke, M. D. Layne, S.-F. Yet, et al. Exacerbation of Chronic Renovascular Hypertension and Acute Renal Failure in Heme Oxygenase-1-Deficient Mice Circ. Res., May 25, 2001; 88(10): 1088 - 1094. [Abstract] [Full Text] [PDF]